VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1677928
Sex: F
Age:
State: OH

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Throwing up for hours; Struggling to stay hydrated and eat anything; Struggling to stay hydrated and eat anything; Terrible migraine; Terrible migraine; Terrible migraine that is limiting vision; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraines. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) and ubidecarenone (COENZYME Q10); both were taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 16:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 03:00, the patient had been throwing up for hours and she was struggling to stay hydrated and eat anything. The patient also had a terrible migraine that was limiting her vision. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events throwing up for hours, struggling to stay hydrated and eat anything, terrible migraine and terrible migraine that is limiting vision was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: FLUOXETINE; COENZYME Q10 [UBIDECARENONE]

Current Illness:

ID: 1677929
Sex: F
Age:
State: VA

Vax Date: 04/19/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Quarter sized rash at injection site; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 19Apr2021 at 12:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 12:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 10:00, the patient had a quarter sized rash at injection site. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measure was not taken as a result of the events. The clinical outcome of the event quarter sized rash at injection site was resolved on 21Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1677930
Sex: F
Age:
State: FL

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Vertigo; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included vasodepressor syncope and allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included vitamin d nos (MANUFACTURER UNKNOWN); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received sulfamethoxazole; trimethoprim(BACTRIM) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 21:00, within 12 hours of the vaccination, the patient experienced vertigo. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event which included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D NOS

Current Illness:

ID: 1677931
Sex: F
Age:
State: MO

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: hives; The person who gave the Covid 19 injection said she hit a blood vessel in the caller's daughter's arm; arm bled a little bit more after injection; allergic to the Covid 19 vaccine; itched all night; hives are around her eyes, the right side of her face it is splotchy and swollen; hives are around her eyes, the right side of her face it is splotchy and swollen; This is a spontaneous report from a contactable consumer or other non hcp (mother). A 19-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8731), via an unspecified route of administration, administered in Arm Left on 08Apr2021 13:30 (at the age of 19-year-old) as dose 1, single for covid-19 immunisation. The patient medical history included suspected covid-19 (Reporter stated that her daughter did have the Covid 19 virus on 21Dec2020). There were no concomitant medications. The patient previously took doxycycline and experienced drug hypersensitivity, doxycycline and experienced urticaria. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, patient experienced the person who gave the covid 19 injection said she hit a blood vessel in the caller's daughter's arm, arm bled a little bit more after injection. On 09Apr2021, patient experienced hives. On an unspecified date in 2021, patient experienced allergic to the covid 19 vaccine, itched all night, hives are around her eyes, the right side of her face it is splotchy and swollen. Hives are on her face, arms, legs, stomach, chest, back, and neck was reported as worsened. Reporter stated that she doesn't think her daughter getting the second vaccine. Obviously she's allergic to the Covid 19 vaccine. The reporter's daughter worked last night, 20Apr2021 and the hives started coming back on her face around 10:00PM. She got off work and lives minutes away. Her hives were getting worse by the second. The reporter's daughter took half a Prednisone pill and 2 more 25mg Benadryl. That didn't even work, she itched all night. Therapeutic measures were taken as a result of hives, allergic to the covid 19 vaccine, itched all night, hives are around her eyes, the right side of her face it is splotchy and swollen included Benadryl 25mg tablets and prednisone 50mg. patient was initially taking 2 Benadryl in the morning and 2 Benadryl at night and that wasn't helping. Patient went to her doctor on 19Apr2021 and the doctor put her on Prednisone 50mg. Once the Prednisone wears off the hives are coming back with a vengeance (as reported). Patient took her first dose of Prednisone morning at 10:00AM and by 10:00PM in night the hives were back, all over her face and the hives were worse than what they were before. The events did not resulted in emergency room visit, however patient visited physician office as a result of hives. The outcome of the events hives, itched all night, hives are around her eyes, the right side of her face it is splotchy and swollen was not recovered, the person who gave the covid 19 injection said she hit a blood vessel in the caller's daughter's arm, allergic to the covid 19 vaccine was unknown and arm bled a little bit more after injection was recovered on 08Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677932
Sex: F
Age:
State: NJ

Vax Date: 03/23/2021
Onset Date: 04/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202103; Test Name: Nasal Swab; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Have ringing in my ears, which never had before.; Dizziness; Foggy head; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Mar2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced ringing in ears which the patient never had before, dizziness and a foggy head. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Mar2021, the patient underwent nasal swab and the result was unknown. The clinical outcome of the events ringing in ears, dizziness and foggy head was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677933
Sex: M
Age:
State: CA

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 09:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 21:00, the patient experienced headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677934
Sex: M
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Sore muscles; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), zinc (MANUFACTURER UNKNOWN) and sitosterol (CHOLEST-OFF); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 the patient experienced sore muscles and injection site pain. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore muscles and injection site pain were not resolved at this time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; ZINC; CHOLEST-OFF

Current Illness:

ID: 1677935
Sex: M
Age:
State: CA

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: All over body chills; Fever; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 21Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included magnesium (MANUFACTURER UNKNOWN), vitamin b (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), fish oil (MANUFACTURER UNKNOWN) and iron (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 31Mar2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 04:00, the patient experienced all over body chills, fever and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as the result of events. The clinical outcome of the events all over body chills, fever and headache were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: MAGNESIUM; VITAMIN B [VITAMIN B COMPLEX]; VITAMIN C [ASCORBIC ACID]; FISH OIL; IRON

Current Illness:

ID: 1677936
Sex: U
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Pain in underarm lymph node that started two days after second dose and persisted for 4 days; Also had nausea the night of the second dose; This is a spontaneous report from a non-contactable consumer, the patient. A patient of an unknown gender and age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 17:00 as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included oral birth control (MANUFACTURER UNKNOWN) from an unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced pain in underarm lymph node that started two days after second dose and persisted for four days. It was reported that the patient did not experience this pain during the first dose, also had nausea the night of the second dose. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in underarm lymph node, nausea was recovered on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677937
Sex: M
Age:
State: VA

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Vertigo after 20 hours of injection. two days later still have vertigo.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8736) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver and primary biliary cholangitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ursodeoxycholic acid (URSODIOL) for unknown indication on unknown date and unknown if ongoing. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: GP7533) via an unspecified route of administration in the left arm on 26Mar2021 at 10:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 00:00, 20 hours after vaccination, the patient experienced vertigo. Two days later still the patient had vertigo. The event did not result in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was not recovered at the time of the this report. No follow-up attempts are needed. No further information is expected.

Other Meds: URSODIOL

Current Illness:

ID: 1677938
Sex: F
Age:
State: CA

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Urine turned neon yellow; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 14:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fluvoxamine maleate (LUVOX) for an unknown indication from an unknown date and unknow if ongoing. On 21Apr2021 at 20:30, the patient urine turned neon yellow later that night. The next day, patient's urine was still a bit yellow now, but much less than before. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of adverse event. The clinical outcome of the event urine turned neon yellow was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LUVOX [FLUVOXAMINE MALEATE]

Current Illness:

ID: 1677939
Sex: F
Age:
State: MA

Vax Date: 04/17/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Swollen armpit/lymph nodes in the arm where shot was given.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Apr2021 at 11:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Apr2021, the patient experienced swollen armpit/ lymph nodes in the arm where shot was given. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of both the event swollen armpit/ lymph nodes in the arm where shot was given was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677940
Sex: F
Age:
State: VA

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Dizzy; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Apr2021, the patient felt dizzy. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizzy was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677941
Sex: M
Age:
State: OH

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: The second dose has given me terrible headaches; Pain in the left arm; Pain in the left armpit; I am unable to fully use my left arm. The mobility of it is highly restricted due to the pain in the bicep/armpit.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732) via an unspecified route of administration in the left arm on 20Apr2021 at 14:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, osteoarthritis, hypertension, pre-diabetes and psoriasis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bisoprolol (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and metformin (MANUFACTURER UNKNOWN) all for an unknown indications since an unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6202) via an unspecified route of administration in the left arm on 31Mar2021 at 12:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 21:00, the second dose had given the patient terrible headaches, pain in his left arm / left armpit that was of a similar feeling to a torn muscle (specifically centered around the vaccination site) and the patient was unable to fully use his left arm. The mobility of it was highly restricted due to the pain in the bicep / armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events terrible headaches, pain in the left arm / left armpit and mobility was highly restricted was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BISOPROLOL; HYDROCHLOROTHIAZIDE; METFORMIN

Current Illness:

ID: 1677942
Sex: M
Age:
State: NY

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Huge headache and felt very weak for the entire next day; Huge headache and felt very weak for the entire next day; Nausea and massive feeling of imbalance.; Nausea and massive feeling of imbalance.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Apr2021 at 18:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. Concomitant medications taken within two weeks of vaccination included escitalopram oxalate (LEXAPRO), bupropion hydrochloride (WELLBUTRIN) and Probiotics; all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 29Mar2021 at 18:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 21:00, the patient experienced nausea and massive feeling of imbalance. The patient experienced huge headache and felt very weak for the entire next day on 20Apr2021. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events nausea and massive feeling of imbalance, huge headache and felt very weak for the entire next day was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEXAPRO; WELLBUTRIN

Current Illness:

ID: 1677943
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Dizziness; Nauseous; Vomiting; This is a spontaneous report from a non-contactable consumer. A 19-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Apr2021 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021, the patient experienced nauseous/vomiting for 4 days and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Apr2021, the patient underwent nasal swab test for COVID-19 and the result was negative. Therapeutic measures were taken as a result of nauseous/vomiting and included treatment with unspecified anti-nausea medication. The clinical outcome of the events nauseous and vomiting were recovered on 23Apr2021 while dizziness was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677944
Sex: F
Age:
State: DC

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Headache; Left arm pain; Back pain; Vaginal pain; Hot flashes; Lack of appetite; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 15:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse, allergy to nuts (tree nuts), allergy (poppy seeds) and sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) taken for unknown indication on unknown date and unknown if ongoing. The patient previously took cefdinir (OMNICEF) and tobramycin (TOBREX); both on unknown dates for unspecified indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 at 09:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. On 23Apr2021 at 05:30, the patient experienced headache, left arm pain, back pain, vaginal pain, hot flashes and lack of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, left arm pain, back pain, vaginal pain, hot flashes and lack of appetite were resolved on 23Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D NOS

Current Illness:

ID: 1677945
Sex: F
Age:
State: TX

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Cannot drive well; Focus in last two days.; Mild headache.; Feeling pain in collar bone up to skull; Pain in collar bone area on left side, when touched the tender area, felt puffy/swollen; Throbbing pain /woke up with the pain going from her left shoulder to her back, where her shoulder blade is and up her back; Joint pain in left wrist, elbow and shoulder; Tenderness where the shot was given in left arm.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in left arm on 16Apr2021 at 12:00, (at the age of 42-years old) as a single dose for COVID-19 immunisation. The patient's medical history and allergies were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included birth control medications (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in left arm on 29Mar2021 at 12:00, (at the age of 42-years old) as a single dose for COVID-19 immunisation. On 16Apr2021, on the day of second shot, the patient had only tenderness where the shot was given in left arm. On 17Apr2021 at 13:00, the patient experienced joint pain in left wrist, elbow and shoulder, with throbbing pain if moved and the patient tried to lay down once pain started, but to get up for bathroom and to eat or drink something, the pain got intensified. The patient tried to hold her arm in a sling position to try not to use. On 18Apr2021, the patient woke up feeling pain in her collar bone area on left side, when she touched the tender area, it felt puffy or swollen, it was reported that patient's oldest looked and said that it was bloated compared to right and pain continued the whole day. On 19Apr2021, the patient woke up with the pain going from her left shoulder to her back, where her shoulder blade is and up her back. The patient also had mild headache. The patient also reported that her arm didn't feel as bad as the weekend, so she thought it was getting better. From 19Apr2021 to 21Apr2021, the pain in shoulder was subtle or light. On 22Apr2021, still the pain in shoulder, collar bone up to the skull which was painful. On 21Apr2021, the patient was not able to drive well or focus in last two days. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events, tenderness where the shot was given in left arm, joint pain in left wrist, elbow and shoulder, feeling pain in her collar bone area to skull, tender area felt puffy or swollen, throbbing pain/ pain going from left shoulder to up back where shoulder blade is, mild headache, cannot drive well or focus and pain in shoulder and collar bone up to skull was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677946
Sex: F
Age:
State: NJ

Vax Date: 04/09/2021
Onset Date: 04/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Ringing in ears (previously had it maybe 1 or 2 days per month) much worse and all the time; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 50-years-old) as single dose for COVID-19 immunisation. Medical history included migraine and ongoing tinnitus. Prior to vaccination, the patient was not diagnosed with COVID-19. On 13Apr2021, the patient experienced ringing in ears (previously had it for 1 or 2 days per month) much worse and all the time. Pitch of ringing went up and down throughout day. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event ringing in ears (previously had it for 1 or 2 days per month) much worse and all the time was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds: SERTRALINE

Current Illness: Tinnitus (Previously had it maybe 1 or 2 days per month)

ID: 1677947
Sex: M
Age:
State: VT

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Injection site soreness; Fatigue; Mild headache; This is a spontaneous report from a non-contactable pharmacist. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within 2 weeks of the vaccination and other vaccines within four weeks prior to the COVID vaccine. On 02Apr2021, the patient experienced injection site soreness, fatigue and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site soreness, fatigue and mild headache were resolving at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1677948
Sex: F
Age: 77
State: CO

Vax Date: 08/28/2021
Onset Date: 09/02/2021
Rec V Date: 09/07/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: This patient was hospitalized with cardiac valve thrombosis within 5 days of being administered the 3rd booster immunization. patient was then put on a heparin infusion to manage the thrombosis and then proceeded to develope a 15mm subdural hematoma.

Other Meds:

Current Illness:

ID: 1677949
Sex: F
Age:
State: MI

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Headache; Fatigue; Chills; Fever; ache moving down through neck,; Joint pain; Weakness in knees, ankles, arms; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 21Apr2021 at 11:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included Barrett's esophagus and food allergies (Zucchini and seafood/fish). The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 as a single dose for COVID-19 immunisation. On 21Apr2021, the patient had sudden onset of headache and fatigue after approximately 10 hours sudden onset of chills approximately 11 hours. Fever and constant shivering and ache moving down through neck, shoulders, and lower back after approximately 12.5 hours. Joint pain and weakness in knees, ankles, arms after approximately 13 hours. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, chills, fatigue, neck pain, shoulders pain, lower back pain, joint pain and weakness in knees, ankles, arms was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677950
Sex: M
Age:
State: IL

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Tiredness; Lack of energy; Foggy; excessive yawning.; Sore arm; This is a spontaneous report from a contactable healthcare professional, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 15:00 (at the age of 41-year-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient previously took Aspirin and experienced allergy to it. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valaciclovir (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN), both for unknown indication and from an unknown date. On 15Apr2021, on the day on vaccination the patient experienced sore arm. On 21Apr2021, the patient had tiredness/lack of energy, foggy, and excessive yawning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, tiredness/lack of energy, foggy, and excessive yawning was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VALACYCLOVIR [VALACICLOVIR]; BUPROPION

Current Illness:

ID: 1677951
Sex: F
Age:
State: PA

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: injection site pain; tiredness; headache; muscle pain; chills; fever; joint pain; throat hurts; tongue sensitive (burn sensation); tongue sensitive (burn sensation); start spotting brown blood; This is a spontaneous report from a contactable consumer (patient). A 44-years-old non pregnant female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 20Apr2021 12:00 (at the age of 44-years old) (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had no medical history. The patient had no known allergies. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks, no covid prior vaccination and no covid tested post vaccination. The patient experienced injection site pain, tiredness, headache, muscle pain, chills, fever, joint paint, throat hurts, tongue sensitive (burn sensation), start spotting brown blood on 20Apr2021 13:00. The latency between suspect and event was of 1 hour. The patient received no treatments in response to events. The clinical outcome of events was unknown. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677952
Sex: F
Age:
State: IL

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Eyes were twitching and kept switching from right to left; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced eyes were twitching and kept switching from right to left for 2 days after the first vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event eyes was twitching and kept switching from right to left was recovered on 02Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677953
Sex: M
Age:
State: AZ

Vax Date: 04/04/2021
Onset Date: 04/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Dizziness when stand up; Dizziness when move too fast; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included aortic stenosis. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced dizziness when moved too fast or stood up. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events which included prescribed medications for dizziness. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness when stand up and dizziness when move too fast was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VALSARTAN

Current Illness:

ID: 1677954
Sex: F
Age:
State: NJ

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Sore arm; Slight chills; Low energy; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 22Apr2021 at 19:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as thyroid cancer survivor. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (SYNTHROID 88), cetirizine hydrochloride (ZYRTEC), paracetamol (TYLENOL ES), multivitamin (MANUFACTURER UNKNOWN) and vi (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 01Apr2021 at 19:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 09:30, the patient experienced sore arm, slight chills and low energy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events sore arm, slight chills and low energy was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; TYLENOL EXTRA-STRENGTH

Current Illness:

ID: 1677955
Sex: F
Age:
State: NC

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: migraine headache; light sensitivity; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 12:15 (at the age of 57-year-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 15Apr2021 at 11:45 (at the age of 57-year-old) as a dose for COVID-19 immunisation. Medical history included penicillin allergy, migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On an unknown date in Mar2021, the patient experienced a migraine headache with light sensitivity (About 3 days post both vaccines). The migraine and light sensitivity was worse after the second shot. Patient stated that she had migraines before, but would not say that she was a habitual migraine sufferer. In the past, they had only been brought on by stress or loud perfumes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine headache with light sensitivity, the migraine and light sensitivity was worse after the second shot was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677956
Sex: M
Age:
State: MD

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to dust mite and pollen. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) and budesonide/ formoterol fumarate (SYMBICORT); both from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 13:00, the patient experienced dry mouth. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event dry mouth was unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: MONTELUKAST; SYMBICORT

Current Illness:

ID: 1677957
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Within four hours of receiving the vaccine body started shaking slightly; Another couple hours go by and entire body was jerking,; Could not even walk; Teeth were chattering; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 21Apr2021 at 18:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux when the patient was younger kid. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 31Mar2021 at 18:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 21Apr2021 at 22:00, within four hours of receiving the vaccine, the patient experienced body shaking slightly, another couple hours go by and the entire body was jerking and her teeth were chattering (all uncontrollably). The patient could not even walk due to how intensely the jerking/shaking was. This continued all through the night, and didn't stop until around 8:00 the following morning. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of events body started shaking slightly, the entire body was jerking, could not even walk and teeth were chattering were unknown at this time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677958
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/16/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Speechless; Brain fog; Anxiety attack; Feel awful.; Fever; Muscle ache; Chills; Tingling in head and lowered back; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old, non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration on 09Apr2021 at 13:45 (at an age of 40-years-old) as single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. The patient did not receive any concomitant medications. On 16Apr2021, the patient had tingling in head and lowered back, chills, fever, speechless, brain fog, anxiety attack, muscle ache symptoms were on going for a week, felt awful. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of tingling in head and lowered back, chills, fever, speechless, brain fog, anxiety attack, muscle ache and felt awful were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677959
Sex: M
Age:
State: NJ

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Metallic taste in mouth; This is a spontaneous report from a contactable consumer. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Apr2021 (age at vaccination unknown) as a single dose for COVID-19 immunisation. It was unknown if the patient had any other medical history and known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was not known if the patient received any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient experienced metallic taste in mouth. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event metallic taste in mouth was resolved on 23Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677960
Sex: F
Age:
State: NY

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Tiredness; Low back stiffness; pain; Severe shoulder pain; burning; cannot lift arm; Painful armpit; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 45-year-old Adult female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 19Apr2021 at 08:00 AM (Lot number: Unknown) (at the age of 45-year-old) as DOSE 1, SINGLE for covid-19 immunisation.The patient was not pregnant at the time of vaccination. Medical history included Known allergies to Fragrances. The patient was not diagnosed with COVID-19, Prior to vaccination. Concomitant medications included Multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Apr2021, the patient experienced tiredness, low back stiffness, pain, severe shoulder pain, burning and cannot lift arm and painful armpit. No treatment was received to treat the events. The patient outcome of the events was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1677961
Sex: M
Age:
State:

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: I developed tinnitus, a ringing in the ears after my first shot which I never had; It became even worse after the 2nd dose; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) on an unknown date as a single dose for COVID-19 immunisation. The patient did not have any medical history. Concomitant medications included dexmethylphenidate hydrochloride (FOCALIN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 20:00 after the first vaccination the patient experienced tinnitus, a ringing in the ears which patient had never had. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) on 21Apr2021 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021 (after the second vaccination) Patient reported that the event tinnitus had worsened. The patient reported that the hearing was checked and there appeared to be no reduction in hearing, but the ringing was having an impact. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tinnitus and tinnitus condition worsened were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: FOCALIN [DEXMETHYLPHENIDATE HYDROCHLORIDE]

Current Illness:

ID: 1677962
Sex: M
Age:
State: OH

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Arm soreness; Drowsiness; Overall muscle ache; This is a spontaneous report from a contactable consumer. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via intramuscular route of administration in the left arm on 23Apr2021 at 10:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via intramuscular route of administration in the left arm on 01Apr2021 at 11:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 19:00, the patient experienced arm soreness, drowsiness and overall muscle ache. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm soreness, drowsiness and overall muscle ache was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677963
Sex: F
Age:
State: FL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210726; Test Name: MRI of right hand; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210518; Test Name: X-ray of heart; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210616; Test Name: X-ray of right hand; Result Unstructured Data: Test Result:Unknown result; Comments: injured when passed out and fell

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: hives on left side of neck; Diarrhea; extremely tired; The initial case was missing the following minimum criteria: ICH-Unspecified AE. Upon receipt of follow-up information on 28Jul2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (Patient). A 75-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EP6955 and Expiry date was not reported), via an intramuscular route of administration on 15Mar2021 10:30 (at the age of 75-years-old) in Arm Left as dose 1, single for COVID-19 immunization. The patient Medical history included hypoglycaemia from 1967 and ongoing N/A: Control with Diet, ongoing pericardial cyst and prolapsed mitral valve, vein procedure legs from an unknown date to Jan2018 Pertinent Details: 30Nov2017, 14Dec2017, 25Jan2018 , skin cancer on nose from an unknown date to Jan2014 , diabetes and stroke from an unknown date and unknown if ongoing Fathers Side- Diabetes and Stroke, Mothers Side- Heat Problems and Stroke. There were no concomitant medications. Prior vaccinations within 4 weeks was None. Patient just wants to get over to the medical line. She doesn't want to do a follow up. She wants to find out more information about her side effects. She had minor side effects with the first COVID vaccine. She cannot believe it because she was normally a healthy person.On 15Mar2021, the patient experienced hives on left side of neck, diarrhoea, extremely tired. The patient received treatment with Benadryl for hives mainly rest. The patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8729and Expiry date was not reported), via an intramuscular route of administration on 12Apr2021 10:45 (at the age of 75-years-old) in Arm Left as dose 2, single for COVID-19 immunization. The patient underwent lab tests and procedures which included magnetic resonance imaging: unknown result on 26Jul2021, x-ray: unknown result on 18May2021, x-ray: unknown result on 16Jun2021 injured when passed out and fell. The outcome for the events hives on left side of neck, diarrhoea, extremely tired was recovered on 19Mar2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness: Hypoglycemia (N/A: Control with Diet); Pericardial cyst; Prolapsed mitral valve

ID: 1677964
Sex: M
Age:
State: CA

Vax Date:
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Very high fever; Body ache; Headaches; Sensitive to light and noises; Sensitive to light and noises; Lack of appetite; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic cough. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 17:00, the patient experienced very high fever, body ache, headaches, sensitive to light and noises and lack of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with Acetaminophen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very high fever, body ache, headaches, sensitive to light and noises and lack of appetite was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677965
Sex: F
Age:
State: AZ

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Shingles- 14 days after second vaccine; Dead arm; Back pain; Fever; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Apr2021 at 17:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 17:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021, the patient experienced dead arm, back pain, fever, chills and nausea. On 10May2021, 14 days after second vaccine, the patient experienced shingles. The adverse events resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The patient received valacyclovir hydrochloride (VALTREX) as treatment for the reported events. The clinical outcome of the events dead arm, back pain, fever, chills, nausea and shingles was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677966
Sex: M
Age:
State: CA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Joint pain started after first 24 hours across entire body.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 03May2021 at 16:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 after the first 24 hours (also reported at 15:30), the patient experienced joint pain across the entire body. It had since subsided everywhere, but constant, persistent pain continued in both the knees, whereas previously, there was no joint pain. The patient had no history of joint pain. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event joint pain across entire body and persistent pain continued in both the knees was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677967
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Numbness in left leg and foot; Joint pain in hands, wrists, elbows, shoulders, knees ankles and feet; Restricting mobility; Restricting ability to do everyday tasks; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 21Apr2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19.Concomitant medication was not reported. The patient previously took rofecoxib (VIOXX) and experienced drug allergy and took ciprofloxacin (CIPRO) and experienced allergy to antibiotic; both on unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm on 24Mar2021 at 16:30 (at the age of 54-years-old) , as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Apr2021 at 23:00 the patient experienced numbness in left leg and foot, joint pain in hands, wrists, elbows, shoulders, knees ankles and feet that restricted mobility and ability to do everyday tasks for the patient. The patient experienced extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with over the counter ibuprofen for pain or inflammation. The clinical outcome of the events numbness in left leg and foot, joint pain in hands, wrists, elbows, shoulders, knees ankles and feet, restricting mobility, restricting ability to do everyday tasks and extreme fatigue were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677968
Sex: M
Age:
State: NY

Vax Date: 04/26/2021
Onset Date: 05/07/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Diagnosed with shingles on the left side of my abdomen and back; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 26Apr2021 at 09:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 22:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 06:00, the patient was diagnosed with shingles on the left side of abdomen and back. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event and included treatment with unspecified anti-viral medication. The clinical outcome of the event shingles was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677969
Sex: M
Age:
State: CO

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Full body aches; Nausea; Vomiting; Fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 14:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atomoxetine hydrochloride (STRATTERA) for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 11Apr2021 at 11:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 13May2021 at 03:00 the patient experienced full body aches, nausea, vomiting, fever, fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events full body aches, nausea, vomiting, fever, fatigue and headache were resolving at the time of report. No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: STRATTERA

Current Illness:

ID: 1677970
Sex: M
Age:
State: CT

Vax Date: 12/23/2020
Onset Date: 01/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Hearing test; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: ringing in the left ear; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration in the left arm on 23Dec2020 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. The patient was allergic to intravenous pyelogram (IVP) dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cyanocobalamin (B-12), esomeprazole sodium (NEXUIM), losartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and rosuvastatin calcium (ROSUVAS); all taken from unknown dates for unknown indications and unknown if ongoing. On an unknown date in Jan2021, the patient experienced ringing in the left ear. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient underwent hearing tests and the results were unknown. Therapeutic measures were taken as a result of the event and included treatment with hearing tests and changing of medications (unspecified). The clinical outcome of the event ringing in the left ear was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: B-12; NEXIUM [ESOMEPRAZOLE SODIUM]; LOSARTAN; HYDROCHLOROTHIAZIDE; ROSUVAS

Current Illness:

ID: 1677971
Sex: M
Age:
State: CT

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Soreness persisted in my left shoulder, and then spread to other large muscles/ Wrists and shoulders became so painful/ arthritic joint pain; Tight muscles made tendons sore.; The large muscle pain and cramps; The large muscle pain and cramps; Arthritic joint pain perhaps tendonitis.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 16Apr2021 at 12:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and very mild arthritis. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 11:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 17Apr2021, the patient experienced soreness persisted in the left shoulder and then spread to other large muscles, tight muscles made tendons sore, wrists and shoulders became so painful that the patient had difficulty pulling covers up at night, and buttoning shirts, the large muscle pain and cramps were currently getting better, but still had what could best be described as arthritic joint pain and perhaps tendonitis. The patient had made an appointment to discuss these issues with his doctor. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcomes of the events soreness persisted in the left shoulder and then spread to other large muscles, tight muscles made tendons sore, wrists and shoulders became so painful that the patient had difficulty pulling covers up at night, and buttoning shirts, the large muscle pain and cramps were currently getting better, but still had what could best be described as arthritic joint pain and perhaps tendonitis were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677972
Sex: M
Age:
State: KS

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: bump still remains from shot; itchy; Every morning I feel as though I may vomit.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: LDCPH) via an unspecified route of administration in the left arm on 20Apr2021 at 05:30 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: LDCPH) via an unspecified route of administration in the left arm on 31Mar2021 as a single dose for COVID-19 immunisation. On 21Apr2021 at 09:15, every morning, the patient felt as though he may vomit, bump still remains from shot and itchy a few times. Therapeutic measures were not taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome for the events felt as though he may vomit, bump still remains from shot and itchy a few times were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677973
Sex: M
Age:
State: NJ

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Moderate injection site pain; Mild redness around injection site; Mild swelling around injection site; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 12May2021 at 16:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) and major depressive disorder (MDD). The patient had known allergies to lactose. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), lamotrigine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and buspirone hydrochloride (BUSPIRON); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 22:00, the patient experienced moderate injection site pain, mild redness around injection site and mild swelling around injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events moderate injection site pain, mild redness around injection site and mild swelling around injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VYVANSE; LAMOTRIGINE; HYDROCHLOROTHIAZIDE; BUSPIRON [BUSPIRONE HYDROCHLORIDE]

Current Illness:

ID: 1677974
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Jaw pain; Lightheadedness; Itching/pins and needles sensation throughout right arm; Itching/pins and needles sensation throughout right arm; Soreness at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date, in 2021 the patient experienced light headedness for about 1 hour after vaccination, itching/pins and needles sensation throughout right arm for about 2 hours after vaccination, moderate jaw pain for 48 hours after vaccination and intense soreness at vaccination site starting 12 hours after vaccination which lasted for 48 hours after vaccination. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events light headedness was resolved on an unknown date, in 2021 (after duration of 1 hour), itching/pins and needles sensation throughout right arm was resolved on an unknown date, in 2021 (after duration of 2 hours), soreness at injection site was resolved on an unknown date, in 2021 (after duration of 36 hours) and jaw pain was resolved on an unknown date, in 2021 (after duration of 48 hours). No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677975
Sex: M
Age:
State: TX

Vax Date: 05/10/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210512; Test Name: Body temperature; Result Unstructured Data: Test Result:101

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Swollen lymph nodes; Fever 101; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 10May2021 at 09:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medication taken within two weeks of vaccination was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 08:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 12May2021 at 06:00, the patient experienced swollen lymph nodes and fever 101. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. On 12May2021, the patient recorded body temperature and the result was 101 (unit unspecified). The clinical outcome of the events swollen lymph nodes was not recovered and that of fever 101 was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677976
Sex: M
Age:
State: MA

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210501; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:[degF]

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Pyrexia (102*F); Shivering; Myalgia; Non productive cough; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 30Apr2021 at 19:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included HSV-2 Infection (patient reported no lesions or symptoms at time of vaccine or afterward) and COVID-19. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. On 01May2021 at 08:00, within 12 hours, the patient experienced pyrexia 102*F, shivering, myalgia, non-productive cough and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pyrexia 102*F, shivering, myalgia, non-productive cough and fatigue were recovered on 02May2021, all symptoms dissipated within 24 hours. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677977
Sex: F
Age:
State: NJ

Vax Date: 04/19/2021
Onset Date: 05/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Tingling in axillary region (bilaterally) and right forearm and back and right pectoral area; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 27Mar2021 at 09:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021, the patient experienced tingling in axillary region (bilaterally) and right forearm and back and right pectoral area. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event (reported "Haven't received anything yet. Doctor's appt in hr"). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling in axillary region (bilaterally) and right forearm and back and right pectoral area was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am